CALR and myeloid neoplasm: In this case report and review of 12 additional cases with concurrent CALR-mutation and BCR-ABL1 fusion, we highlighted the importance of integrated clinical, morphologic, and molecular genetic data for classifying atypical myeloid neoplasms for treatment and responses of patients.